135 related articles for article (PubMed ID: 30089785)
1. CEACAM1 promotes melanoma metastasis and is involved in the regulation of the EMT associated gene network in melanoma cells.
Wicklein D; Otto B; Suling A; Elies E; Lüers G; Lange T; Feldhaus S; Maar H; Schröder-Schwarz J; Brunner G; Wagener C; Schumacher U
Sci Rep; 2018 Aug; 8(1):11893. PubMed ID: 30089785
[TBL] [Abstract][Full Text] [Related]
2. Regulation of CEACAM1 Protein Expression by the Transcription Factor ETS-1 in BRAF-Mutant Human Metastatic Melanoma Cells.
Kfir-Elirachman K; Ortenberg R; Vizel B; Besser MJ; Barshack I; Schachter J; Nemlich Y; Markel G
Neoplasia; 2018 Apr; 20(4):401-409. PubMed ID: 29558679
[TBL] [Abstract][Full Text] [Related]
3. An actionable axis linking NFATc2 to EZH2 controls the EMT-like program of melanoma cells.
Perotti V; Baldassari P; Molla A; Nicolini G; Bersani I; Grazia G; Benigni F; Maurichi A; Santinami M; Anichini A; Mortarini R
Oncogene; 2019 May; 38(22):4384-4396. PubMed ID: 30710146
[TBL] [Abstract][Full Text] [Related]
4. SOX9 indirectly regulates CEACAM1 expression and immune resistance in melanoma cells.
Ashkenazi S; Ortenberg R; Besser M; Schachter J; Markel G
Oncotarget; 2016 May; 7(21):30166-77. PubMed ID: 26885752
[TBL] [Abstract][Full Text] [Related]
5. The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanoma.
Ramsdale R; Jorissen RN; Li FZ; Al-Obaidi S; Ward T; Sheppard KE; Bukczynska PE; Young RJ; Boyle SE; Shackleton M; Bollag G; Long GV; Tulchinsky E; Rizos H; Pearson RB; McArthur GA; Dhillon AS; Ferrao PT
Sci Signal; 2015 Aug; 8(390):ra82. PubMed ID: 26286024
[TBL] [Abstract][Full Text] [Related]
6. RNAi technology to block the expression of molecules relevant to metastasis: the cell adhesion molecule CEACAM1 as an instructive example.
Wicklein D
Methods Mol Biol; 2012; 878():241-50. PubMed ID: 22674138
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of L1CAM significantly reduces metastasis in a xenograft model of human melanoma: L1CAM is a potential target for anti-melanoma therapy.
Ernst AK; Putscher A; Samatov TR; Suling A; Galatenko VV; Shkurnikov MY; Knyazev EN; Tonevitsky AG; Haalck T; Lange T; Maar H; Schröder-Schwarz J; Riecken K; Schumacher U; Wicklein D
PLoS One; 2018; 13(2):e0192525. PubMed ID: 29432466
[TBL] [Abstract][Full Text] [Related]
8. CEACAM1 promotes melanoma cell growth through Sox-2.
Ortenberg R; Galore-Haskel G; Greenberg I; Zamlin B; Sapoznik S; Greenberg E; Barshack I; Avivi C; Feiler Y; Zan-Bar I; Besser MJ; Azizi E; Eitan F; Schachter J; Markel G
Neoplasia; 2014 May; 16(5):451-60. PubMed ID: 24931667
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of Bmi-1 suppresses epithelial‑mesenchymal transition in melanoma.
Liu Y; Chu Z; Li Q; Peng B; Xu S; Lian CG; Geng S
Oncol Rep; 2017 Jan; 37(1):139-146. PubMed ID: 27878257
[TBL] [Abstract][Full Text] [Related]
10. EMT-associated factors promote invasive properties of uveal melanoma cells.
Asnaghi L; Gezgin G; Tripathy A; Handa JT; Merbs SL; van der Velden PA; Jager MJ; Harbour JW; Eberhart CG
Mol Vis; 2015; 21():919-29. PubMed ID: 26321866
[TBL] [Abstract][Full Text] [Related]
11. A longitudinal study of CEACAM1 expression in melanoma disease progression.
Zippel D; Barlev H; Ortenberg R; Barshack I; Schachter J; Markel G
Oncol Rep; 2015 Mar; 33(3):1314-8. PubMed ID: 25573088
[TBL] [Abstract][Full Text] [Related]
12. Macrophage-tumor cell fusions from peripheral blood of melanoma patients.
Clawson GA; Matters GL; Xin P; Imamura-Kawasawa Y; Du Z; Thiboutot DM; Helm KF; Neves RI; Abraham T
PLoS One; 2015; 10(8):e0134320. PubMed ID: 26267609
[TBL] [Abstract][Full Text] [Related]
13. CEACAM1-3S Drives Melanoma Cells into NK Cell-Mediated Cytolysis and Enhances Patient Survival.
Ullrich N; Heinemann A; Nilewski E; Scheffrahn I; Klode J; Scherag A; Schadendorf D; Singer BB; Helfrich I
Cancer Res; 2015 May; 75(9):1897-907. PubMed ID: 25744717
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of Delta-like 3 restricts lipopolysaccharide-induced inflammation, migration and invasion of A2058 melanoma cells via blocking Twist1-mediated epithelial-mesenchymal transition.
Ding X; Li F; Zhang L
Life Sci; 2019 Jun; 226():149-155. PubMed ID: 30981764
[TBL] [Abstract][Full Text] [Related]
15. Astrocyte elevated gene-1 promotes invasion and epithelial-mesenchymal transition in bladder cancer cells through activation of signal transducer and activator of transcription 3.
Yang X; Shi L; Yi C; Yang Y; Chang L; Song D
Int J Urol; 2018 Feb; 25(2):157-163. PubMed ID: 29117631
[TBL] [Abstract][Full Text] [Related]
16. The expression and modulation of CEACAM1 and tumor cell transformation.
Fiori V; Magnani M; Cianfriglia M
Ann Ist Super Sanita; 2012; 48(2):161-71. PubMed ID: 22751559
[TBL] [Abstract][Full Text] [Related]
17. AEG-1 induces gastric cancer metastasis by upregulation of eIF4E expression.
Wu S; Yang L; Wu D; Gao Z; Li P; Huang W; Wang X
J Cell Mol Med; 2017 Dec; 21(12):3481-3493. PubMed ID: 28661037
[TBL] [Abstract][Full Text] [Related]
18. Mapping heterogeneity in patient-derived melanoma cultures by single-cell RNA-seq.
Gerber T; Willscher E; Loeffler-Wirth H; Hopp L; Schadendorf D; Schartl M; Anderegg U; Camp G; Treutlein B; Binder H; Kunz M
Oncotarget; 2017 Jan; 8(1):846-862. PubMed ID: 27903987
[TBL] [Abstract][Full Text] [Related]
19. BRAF and epithelial-mesenchymal transition in primary cutaneous melanoma: a role for Snail and E-cadherin?
Mitchell B; Leone DA; Feller JK; Yang S; Mahalingam M
Hum Pathol; 2016 Jun; 52():19-27. PubMed ID: 26980024
[TBL] [Abstract][Full Text] [Related]
20. Novel immunotherapy for malignant melanoma with a monoclonal antibody that blocks CEACAM1 homophilic interactions.
Ortenberg R; Sapir Y; Raz L; Hershkovitz L; Ben Arav A; Sapoznik S; Barshack I; Avivi C; Berkun Y; Besser MJ; Ben-Moshe T; Schachter J; Markel G
Mol Cancer Ther; 2012 Jun; 11(6):1300-10. PubMed ID: 22466331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
